Barthel et al. (2025) achieved the first genetically encoded control of in vitro transcription–translation coupled DNA replication (TTcDR): in a reconstituted PURE cell-free protein-synthesis system, a DNA-encoded TetR repressor circuit gates expression of Phi29 DNA polymerase, which then replicates the circuit's plasmid by rolling-circle amplification (~1000-fold replication, ~100-fold repression). The fully encoded circuit, however, shows only ~4-fold induction with anhydrotetracycline — versus ~120-fold when TetR is supplied as a purified protein — because TetR is produced without negative feedback (late-phase repression becomes very strong) and because the inducer and other ligands inhibit the reconstituted system at high concentrations. The problem remains open as of August 2026: no published or preprinted work implements encoded, ligand-inducible control of TTcDR with an improved dynamic range. The open problem is to construct such a circuit, resolving both sides of the identified obstruction.

Background

Bottom-up synthetic biology aims to reconstruct minimal cellular functions from purified components and, ultimately, to assemble synthetic cells. A fundamental requirement is that DNA-encoded information can be replicated inside a cell-free system and, crucially, that this replication can be controlled by signals — so that replication can be gated, switched, and eventually coupled to other functions such as metabolism. The workhorse for defined cell-free expression is the PURE system (Protein synthesis Using Recombinant Elements), a reconstituted in vitro transcription–translation (IVTT) mixture assembled from purified Escherichia coli components rather than a crude cell extract, which provides a chemically defined background in which added components can be quantitatively controlled.

Replication itself is contributed by Phi29 DNA polymerase, the highly processive replicative polymerase of bacteriophage Phi29. On circular DNA it performs isothermal rolling-circle amplification (RCA), generating long concatemeric copies of the template; on linear DNA it can replicate strand-displacingly when assisted by the terminal-protein priming machinery of the phage. Placing the Phi29 polymerase gene under a promoter that the PURE system can transcribe produces a reaction in which the DNA template encodes the very enzyme that amplifies it: this self-replicating setup is called transcription–translation coupled DNA replication (TTcDR). TTcDR was established by Sakatani, Yomo and Ichihashi (2018), who showed self-replication of circular DNA by a self-encoded polymerase via RCA, and by Libicher, Hornberger, Heymann and Mutschler (2020), who extended self-replication to large synthetic genomes encoding multiple genes.

For control, Barthel, Hoffmann-Becking, Karimov and Erb (2025) turned to allosteric transcription factors (aTFs) — bacterial repressors whose DNA binding is controlled by a small-molecule ligand. They used TetR, which represses promoters containing the tet operator and is released by the ligand anhydrotetracycline (aTc). In their PURE-based TTcDR system, TetR is either coproduced from plasmid DNA (the fully encoded configuration) or supplied as a purified protein; it represses a T7-tetO promoter driving Phi29 polymerase expression, and hence DNA replication. The final encoded circuit achieves approximately 1000-fold DNA replication, roughly 100-fold repression, but only about 4-fold induction with aTc, whereas supplying 500 nM purified TetR yields 750-fold repression and about 120-fold induction. (The repression figure for the encoded configuration is reported as ~100-fold in the paper's abstract and ~150-fold — 149-fold measured — in its Discussion; the discrepancy is inherited from the source itself.) The authors attribute the weak encoded induction to a two-sided problem: on one side, TetR production is not negatively regulated, so repression becomes very strong after the initial reaction phase and full de-repression requires high ligand concentrations; on the other side, aTc and other small molecules inhibit or crosstalk with the reconstituted PURE system (their Fig. S7), capping the usable inducer concentration range.

The purpose of controlling replication is evolutionary. The stated goal is to integrate metabolic in vitro modules — for example synthetic CO2-fixation pathways or lipid biosynthesis — with TTcDR such that the activity of the metabolic module is transduced, through aTF-based circuits, into differential DNA replication, enabling Darwinian evolution of the coupled module inside compartments (e.g., liposomes) on the way to autonomous synthetic cells. In the source's concluding outlook this coupling is framed as a "new opportunity" enabled by the achieved replication control, which "requires coupling the activity of the metabolic in vitro module to DNA replication". Prior steps toward this vision exist: Giaveri et al. (2024) in the same laboratory integrated translation and metabolism in a partially self-synthesizing biochemical network (but without replication coupling), Abil et al. (2024) demonstrated compartmentalized Darwinian evolution of self-replicating DNA in liposome protocells, and the source laboratory itself previously mapped how 13 non-enzyme components of a synthetic metabolic system drastically inhibit in vitro transcription and the PURE system (Barthel et al. 2024) — a key compatibility obstacle the source authors identify for the coupling objective. The construction of fully autonomous synthetic cells, including replication of linear or larger genomes and coordination with membrane biosynthesis, is a widely shared roadmap goal (Kriebisch et al. 2025). Within this agenda, the specific gap the 2025 work left open is the weak dynamic range of encoded, inducible control over in vitro DNA replication.

Problem Statement

The problem left open by Barthel et al. (2025) is to make genetically encoded, ligand-inducible control of in vitro DNA replication usable, toward the programmable, evolvable TTcDR that the source motivates:

Control core. Construct a fully DNA-encoded regulatory circuit operating in a PURE-based TTcDR system (Phi29 DNA polymerase driven by a TetR-type aTF circuit, replicating the circuit's own DNA templates by rolling-circle amplification) whose ligand-induced induction ratio is substantially higher than the demonstrated ~4-fold — the purified-repressor configuration (~120-fold with 500 nM TetR) shows what dynamic range is in principle reachable — while preserving strong repression and high replication output (on the order of 100- to 1000-fold amplification). The design must resolve both sides of the two-sided obstruction identified in the source: continuous, unregulated production of the repressor (no negative feedback), which makes late-phase repression very strong and demands high inducer concentrations; and inhibition or crosstalk of the reconstituted PURE system by the inducer and other ligands at those concentrations.

Motivation and context (not a required deliverable). The source frames the control core as enabling a downstream coupling objective: using encoded regulation of DNA replication to transduce the activity of a metabolic in vitro module — for example a synthetic CO2-fixation pathway — into differential DNA replication, toward Darwinian evolution of coupled metabolic–genetic in vitro systems in compartments. In its concluding outlook the source describes this as a "new opportunity" that "requires coupling the activity of the metabolic in vitro module to DNA replication", and notes the documented incompatibility of metabolic-module components with the PURE system (Barthel et al. 2024) as a known obstacle on that path. It is recorded here as context for why the control core matters, not as a proposition that a complete answer must demonstrate.

Resolving the control core requires a constructed circuit that meets the target and an explanation of why its design resolves both sides of the two-sided obstruction. The relative terms are defined with respect to the source's own benchmarks: 'substantially higher than ~4-fold' means approaching the order of the purified-TetR induction benchmark (~120-fold); a lower achieved induction meets the target only if it is the measured performance of the constructed circuit and is mechanistically justified against the achievable ceiling indicated by that benchmark. 'High replication output' means the order of the source's ~100- to 1000-fold amplification under nonrepressing conditions.

References

  1. Barthel, S.; Hoffmann-Becking, M.; Karimov, I. G.; Erb, T. J. Genetically Encoded Control of In Vitro Transcription–Translation Coupled DNA Replication. ACS Synthetic Biology, 2025, 14(10), 4134–4142. DOI: 10.1021/acssynbio.5c00477. https://doi.org/10.1021/acssynbio.5c00477
  2. Barthel, S.; Hoffmann-Becking, M.; Karimov, I. G.; Erb, T. J. Genetically encoded control of in vitro transcription-translation coupled DNA replication. bioRxiv preprint, posted 2025-07-08. DOI: 10.1101/2025.07.08.663768. https://doi.org/10.1101/2025.07.08.663768
  3. Barthel, S.; Brenker, L.; Diehl, C.; Bohra, N.; Giaveri, S.; Paczia, N.; Erb, T. J. In vitro transcription-based biosensing of glycolate for prototyping of a complex enzyme cascade. Synthetic Biology, 2024, 9, ysae013. DOI: 10.1093/synbio/ysae013. https://doi.org/10.1093/synbio/ysae013 (the source authors' own mapping of 13 non-enzyme components of a synthetic metabolic system that inhibit in vitro transcription and the PURE system)
  4. Sakatani, Y.; Yomo, T.; Ichihashi, N. Self-replication of circular DNA by a self-encoded DNA polymerase through rolling-circle replication and recombination. Scientific Reports, 2018, 8, 13089. DOI: 10.1038/s41598-018-31585-1. https://doi.org/10.1038/s41598-018-31585-1
  5. Libicher, K.; Hornberger, R.; Heymann, M.; Mutschler, H. In vitro self-replication and multicistronic expression of large synthetic genomes. Nature Communications, 2020, 11, 904. DOI: 10.1038/s41467-020-14694-2. https://doi.org/10.1038/s41467-020-14694-2
  6. Giaveri, S.; Bohra, N.; Diehl, C.; Yang, H.; Ballinger, M.; Paczia, N.; Glatter, T.; Erb, T. J. Integrated translation and metabolism in a partially self-synthesizing biochemical network. Science, 2024, 385, 174–178. DOI: 10.1126/science.adn3856. https://doi.org/10.1126/science.adn3856
  7. Abil, Z.; Restrepo Sierra, A. M.; Stan, A. R.; Châne, A.; del Prado, A.; de Vega, M.; Rondelez, Y.; Danelon, C. Darwinian Evolution of Self-Replicating DNA in a Synthetic Protocell. Nature Communications, 2024, 15, 9091. DOI: 10.1038/s41467-024-53226-0. https://doi.org/10.1038/s41467-024-53226-0
  8. Zheng, X.; Gao, W.; Liu, W.-Q.; Zhang, Y.; Huang, S.; Ji, X.; Lu, Y.; Liu, Y.; Ling, S.; Li, J. Reconstituting transcription–translation-coupled DNA replication within complex in vitro biological systems. Nature Communications, 2025, 17, 351. DOI: 10.1038/s41467-025-67411-2. https://doi.org/10.1038/s41467-025-67411-2
  9. Restrepo Sierra, A. M.; Ramirez Gomez, F.; van Tongeren, M.; Sierra Heras, L.; Danelon, C. A synthetic cell with integrated DNA self-replication and lipid biosynthesis. Nature Communications, 2026, 17, 2727. DOI: 10.1038/s41467-026-69531-9. https://doi.org/10.1038/s41467-026-69531-9
  10. Sierra Heras, L.; Danelon, C. Autocatalytic selection of gene functions in synthetic cells. Communications Biology, 2026, 9, 1124. DOI: 10.1038/s42003-026-10372-z. https://doi.org/10.1038/s42003-026-10372-z
  11. Danelon, C.; Sierra Heras, L. Autocatalytic selection of gene functions in vitro. bioRxiv preprint, posted 2025-08-25. DOI: 10.1101/2025.08.25.672052. https://doi.org/10.1101/2025.08.25.672052
  12. Nagai, R.; Chavez Ramirez, C.; Abil, Z. Protein-Primed DNA Replication is Restored in a Modified Cell-Free Protein Synthesis System. ACS Synthetic Biology, 2026, 15(6), 2693–2699. DOI: 10.1021/acssynbio.6c00283. https://doi.org/10.1021/acssynbio.6c00283 (preprint version: CADGE 2.0, Transcription-Translation-Coupled DNA Replication is Improved in a Chemically Modified Cell-Free System, bioRxiv, posted 2026-02-27, DOI: 10.64898/2026.02.27.708527, https://doi.org/10.64898/2026.02.27.708527)
  13. Kriebisch, C. M. E.; Bantysh, O.; Baranda Pellejero, L.; et al. A roadmap toward the synthesis of life. Chem, 2025, 11, 102399. DOI: 10.1016/j.chempr.2024.102399. https://doi.org/10.1016/j.chempr.2024.102399
  14. Baranwal, A. K.; Maerkl, S. J. Microfluidics meets cell-free systems: from molecular engineering to synthetic cells. Current Opinion in Biotechnology, 2025, 96, 103384. DOI: 10.1016/j.copbio.2025.103384. https://doi.org/10.1016/j.copbio.2025.103384